Wave oligonucleotides are synthetic small RNA-targeting molecules designed to reduce, restore or modulate levels of RNA. When included into gene therapies for treating disease they provide effective therapies.
Scientists from UT Southwestern have successfully utilized electromagnetic waves to induce insulin production in mice, opening the door for potential new therapies for diabetes based on an enhanced understanding of genetic coding principles.
Theoretical Background
Wave genetics hinges upon the idea that DNA has a language-like structure, making it susceptible to language modulation. Gariaev’s team successfully demonstrated this idea by using a voice synthesizer to translate English words into frequencies recognized by DNA, before sending this laser beam with this language-modulated frequency through living cells or parasites and seeing immediate and distinct reactions within these organisms – including genes within those cells themselves!
Gariaev’s team discovered that DNA contains genetic information similar to a hologram, leading them to speculate that its shape may play a key role in organism’s spatial-temporal development – potentially providing four-dimensional blueprints of sorts for growth and evolution. Furthermore, these researchers were able to create intricate patterns on these DNA holograms using advanced imaging technologies – leading them towards genetic linguistics: suggesting our genes might use language grounded in fundamental laws of physics and biology that convey messages.
Another intriguing theory underlying this research is that electromagnetic waves can modulate cellular energy to activate genes and control biological processes. The team of researchers have shown how activating gene expression can be affected by specific frequencies associated with music genres as well as specific wavelengths. Furthermore, electromagnetic fields could potentially have many practical applications from restoring damaged organs to prolonging human lives.
Research could lead to a more thorough understanding of the biological mechanisms governing memory and learning, particularly by exploring neural oscillation genes responsible for autism spectrum disorder, ADHD, schizophrenia or related conditions. Furthermore, studying such genes could reveal their causes as well as provide solutions for treating them with pharmaceutical agents.
Beyond its broad ramifications, this research may help scientists gain greater insight into how specific genes impact sleep/wake cycles. Wave’s PRISM platform–with its three distinct targeting modalities–will be utilized by the research team in order to target biological mechanisms responsible for driving this phenomenon.
Methods
Traditional genetic theory centers around nucleotides within DNA sequences and how these sequences are translated and integrated into protein molecules; however, researchers at Wave Life Sciences USA, Inc have discovered that our genomes operate similarly – an astounding discovery which may transform medical research and the treatment of disease.
Researchers employed a frequency-stabilized Helium-Neon laser with two orthogonal optical modes to convert quantum genetic information stored in human DNA into modulated broadband electromagnetic radiation, which was converted to genetically selective radio wave frequencies that caused abnormal cells and blood parasitic cells to self-destruct.
Radio waves were created by modulating the amplitude, phase, and frequency of laser, radio wave, and acoustic radiations using mechanical, electromechanical, acousto-optical or similar wave generators; then sent on their journey via modulators that modulated these waves directly to atypical cells or blood parasites.
At the cell surface, modulated electromagnetic fields produced by wave generators opened pores along cell membranes to inject genetic cargo. It’s similar to when audience members hear sound waves at a concert.
Researchers examined atypical cells and blood parasites for genetic characteristics and determined which were destroyed by radio wave frequencies used by mSEI. After this step was complete, researchers conducted gene-optical scans on them in order to pinpoint any genes responsible for specific genetic traits found within each individual organism.
Results revealed a number of genetic loci associated with both P-wave duration and terminal force, including five not previously associated with either measure. Figure 2 depicts Manhattan plots stratified by ancestry for primary analyses, and regional plots of all significant variants both here and in previous GWAS of P-wave duration and terminal force. Most significant loci shared associations between them both, suggesting the same genetic mechanism could underlie these phenotypes, providing a model for future research into P-wave duration/terminal force dynamics across other populations.
Results
Wave genetics has repeatedly demonstrated, through well-designed and conducted double-blind experiments, its ability to re-grow organs without resorting to surgical interventions or drugs. Furthermore, its researchers have unlocked all aspects of DNA functionality – even “junk DNA”, making its control directly accessible for All Life’s benefit.
Research findings of this project were widely published and cited by other scientists, confirming that biologically active parts of the genome correspond with specific harmonic frequencies and wave patterns. Wave genetics has demonstrated how genome manipulation is possible using non-invasive electromagnetic energy; this innovation opens the way for groundbreaking new technologies such as bioengineered medicines designed to renew organs or extend human lifespan.
However, such powerful technology requires close vigilance in order to prevent misuse and ensure ethical compliance. Furthermore, an understanding of quantum biology and how electromagnetic waves emitted by DNA molecules interact with physical space will also be crucial.
At present, scientists around the globe are conducting studies into proton tunneling and other quantum effects in biological processes, with hopes that their discoveries might allow them to manipulate DNA in ways never imagined and uncover some secrets about aging processes.
In addition, PRISM platform provides various RNA-targeting modalities, including editing, splicing and silencing that can be utilized to treat various diseases. One such therapeutic is WVE-006, an innovative first-in-class RNA editing therapeutic for alpha-1 antitrypsin deficiency (AATD), designed to correct mutant SERPINA1 Z allele transcript and treat liver and lung manifestations associated with this condition.
As this groundbreaking and transformative research was being attacked so aggressively by the Russian Academy of Sciences – an organization supposed to be above politics and personal preferences – due to it making today’s recombinant gene technology seem like early Wright brother aircraft, it speaks volumes. Unfortunately this unfortunate turn of events should take place, since such revolutionary new technologies offer immense beneficial applications to life on this planet.
Conclusions
Wave genetics has revealed an important finding: DNA encodes its genetic code as an extremely complex wave function which can be controlled and altered using electromagnetic fields that transport information. This discovery opens up new research and development avenues within biology.
Linguistic-wave genetics is an approach that demonstrates how gene functions operate at both quantum and molecular levels. Furthermore, it demonstrates how chromosomes are not simply random collections of genes but are actually part of an integrated and coherent system with specific functions; with this approach it’s possible to engineer healthy cells – or even whole organisms! – using this approach.
Research results also demonstrated how Wave Genetics allows us to communicate with DNA at a distance using electromagnetic signals, without electronic devices emitting harmful electromagnetic fields – an incredible breakthrough that will change the way we live our lives!
Studies have also demonstrated that certain cellular frequencies cause certain diseases; these frequencies are known as biological signatures. Wave genetics identifies these frequencies to identify patients at greater risk for certain illnesses – for instance sudden cardiac death has been linked to specific frequencies; by recognizing them more effectively doctors can better identify and treat patients at risk of sudden cardiac death.
Wave Life Sciences’ research efforts are ongoing and more evidence is expected to accumulate with time. Results of their investigations will be published in leading scientific journals; while Wave is focused on taking its lead RNA therapeutics into clinical use. WVE-006, the company’s first-of-a-class oligonucleotide therapy for alpha-1 antitrypsin deficiency (AATTD), is currently under development, with plans to submit clinical trial applications by 2023. Forward-looking statements contained in this press release are made pursuant to the Private Securities Litigation Reform Act of 1995 and involve several risks and uncertainties that could cause actual results to vary materially from those projected, such as development of new products, commercialization of existing ones, regulatory approval of Wave’s products, attainment of its business goals as outlined in Wave’s filings with the Securities and Exchange Commission etc.
